RNTX
Rein Therapeutics
RNTX
RNTX
33 hedge funds and large institutions have $11.8M invested in Rein Therapeutics in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less capital invested
Capital invested by funds: $15.7M → $11.8M (-$3.88M)
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$227K | |
| 2 | +$175K | |
| 3 | +$161K | |
| 4 |
Squarepoint
New York
|
+$117K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$58.9K |
Top Sellers
| 1 | -$494K | |
| 2 | -$401K | |
| 3 | -$401K | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$165K |
| 5 |
Bank of New York Mellon
New York
|
-$135K |